Detection of glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) from patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Wise, David
Louw, Jessica
Krupa, Rachel
Schreiber, Nicole A.
Sawyers, Charles L.
Dittamore, Ryan Vance
Scher, Howard I.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.
    Li, Jing
    Beaver, Joshua
    Bitting, Rhonda Lynn
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
    Reyes, Edwin E.
    VanderWeele, David J.
    Isikbay, Masis
    Duggan, Ryan
    Campanile, Alexa
    Stadler, Walter M.
    Griend, Donald J. Vander
    Szmulewitz, Russell Z.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [33] Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
    Edwin E Reyes
    David J VanderWeele
    Masis Isikbay
    Ryan Duggan
    Alexa Campanile
    Walter M Stadler
    Donald J Vander Griend
    Russell Z Szmulewitz
    Journal of Translational Medicine, 12
  • [34] Comparison of microfilter-based capture to CellSearch out detection of circulating tumor cells (CTCs) in patients with metastatic castration-resistant prostate cancer (mCRYCa)
    Kyriakopoulos, Christos
    Elson, Paul
    Borden, Ernest C.
    Williams, Anthony
    Ao, Zheng
    Rawal, Siddarth
    Datar, Ram H.
    Cote, Richard J.
    Garcia, Jorge A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer
    Theil, Gerit
    Schmidt, Stefanie
    Fischer, Kersten
    Lucke, Klaus
    Fornara, Paolo
    CANCER RESEARCH, 2016, 76
  • [36] A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Danila, Daniel Costin
    Waterhouse, David Michael
    Appleman, Leonard Joseph
    Pook, David William
    Matsubara, Nobuaki
    Dorff, Tanya B.
    Lee, Jae-Lyun
    Armstrong, Andrew J.
    Kim, Miso
    Horvath, Lisa
    Sumey, Christopher Joseph
    Cooner, Freda
    Salvati, Mark
    Stieglmaier, Julia
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Characterizing longitudinal molecular changes in ctDNA in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Tran, Eli
    Jani, Chinmay
    Zhang, Nicole
    Tsai, Jill
    Pan, Elizabeth
    Panian, Justine
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 205 - 205
  • [38] Multiplexed protein and gene profiling of circulating tumor cells (CTCs) in metastatic castration-resistant prostate cancer (mCRPC) using automated immunofluorescence and fluorescence in situ hybridization
    Nagy, Dea
    Tucker, Eric
    Rajkovich, Samatha
    French, Steven
    Garsha, Karl
    Yun, Steve
    Smith, Katherine
    Sallam, Karim
    Liabotis, Elias
    Otter, Michael
    Marrinucci, Dena
    Dittamore, Ryan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [39] Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Agarwal, Neeraj
    Pond, Gregory Russell
    Nagy, Rebecca J.
    Nussenzveig, Roberto H.
    Hahn, Andrew W.
    Sartor, Oliver
    Gourdin, Theodore Stewart
    Nandagopal, Lakshminarayanan
    Ledet, Elisa M.
    Naik, Gurudatta
    Armstrong, Andrew J.
    Wang, Jue
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Grivas, Petros
    Pal, Sumanta K.
    Lanman, Richard B.
    Talasaz, AmirAli
    Lilly, Michael B.
    CANCER, 2019, 125 (09) : 1459 - 1469
  • [40] Treatment (Rx) patterns and attrition rates in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Gebrael, Georges
    Jo, Yeonjung
    Hage Chehade, Chadi
    Ozay, Zeynep Irem
    Sayegh, Nicolas
    Ostrowski, Micah
    Campbell, Patrick
    Anderson, Ethan
    Nordblad, Blake
    Galarza Fortuna, Gliceida M.
    Mathew Thomas, Vinay
    Riaz, Irbaz Bin
    Graf, Ryon P.
    Guha, Avirup
    Maughan, Benjamin L.
    Roy, Soumyajit
    Antonarakis, Emmanuel S.
    Agarwal, Neeraj
    Swami, Umang
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345